United Therapeutics Corporation (UTHR) — Financial Flexibility Index
United Therapeutics Corporation (UTHR) has a Financial Flexibility Index of 1.02x as of September 2025. Free cash flow of $772.60 Million (operating CF $562.10 Million minus capex $210.50 Million) represents 1% of total liabilities ($760.90 Million). Check United Therapeutics Corporation strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
United Therapeutics Corporation Financial Flexibility Index (1998–2024)
Historical Financial Flexibility Index trend for United Therapeutics Corporation across 27 annual periods. See United Therapeutics Corporation (UTHR) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for United Therapeutics Corporation (1998–2024)
Year-by-year free cash flow to debt coverage for United Therapeutics Corporation. For the full company profile including market capitalisation, see market value of United Therapeutics Corporation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.71x | $1.57 Billion | $1.33 Billion | $920.00 Million | ▲ +67.3% |
| 2023 | 1.02x | $1.21 Billion | $978.00 Million | $1.18 Billion | ▲ +35.5% |
| 2022 | 0.75x | $941.30 Million | $802.50 Million | $1.25 Billion | ▲ +27.0% |
| 2021 | 0.59x | $719.00 Million | $598.20 Million | $1.21 Billion | ▼ -11.1% |
| 2020 | 0.67x | $815.00 Million | $755.70 Million | $1.22 Billion | ▲ +716.0% |
| 2019 | -0.11x | $-122.90 Million | $-206.60 Million | $1.13 Billion | ▼ -106.9% |
| 2018 | 1.57x | $962.80 Million | $778.40 Million | $612.40 Million | ▲ +118.1% |
| 2017 | 0.72x | $560.50 Million | $474.20 Million | $777.60 Million | ▼ -51.4% |
| 2016 | 1.48x | $686.80 Million | $643.60 Million | $463.40 Million | ▲ +100.4% |
| 2015 | 0.74x | $432.59 Million | $382.80 Million | $584.80 Million | ▲ +13.7% |
| 2014 | 0.65x | $402.74 Million | $355.30 Million | $618.84 Million | ▲ +11.5% |
| 2013 | 0.58x | $457.18 Million | $425.27 Million | $783.26 Million | ▼ -28.7% |
| 2012 | 0.82x | $435.53 Million | $323.63 Million | $531.73 Million | ▲ +63.0% |
| 2011 | 0.50x | $286.17 Million | $250.19 Million | $569.59 Million | ▲ +19.6% |
| 2010 | 0.42x | $230.17 Million | $211.53 Million | $547.75 Million | ▼ -14.2% |
| 2009 | 0.49x | $195.12 Million | $99.72 Million | $398.54 Million | ▲ +136.7% |
| 2008 | 0.21x | $75.22 Million | $-49.20 Million | $363.62 Million | ▼ -31.2% |
| 2007 | 0.30x | $87.61 Million | $48.95 Million | $291.23 Million | ▲ +26.7% |
| 2006 | 0.24x | $65.02 Million | $49.39 Million | $273.94 Million | ▼ -92.1% |
| 2005 | 3.02x | $49.28 Million | $43.17 Million | $16.31 Million | ▲ +80.4% |
| 2004 | 1.67x | $26.00 Million | $20.78 Million | $15.52 Million | ▲ +1361.6% |
| 2003 | -0.13x | $-1.56 Million | $-8.56 Million | $11.74 Million | ▲ +90.8% |
| 2002 | -1.45x | $-18.68 Million | $-22.26 Million | $12.91 Million | ▲ +40.5% |
| 2001 | -2.43x | $-38.21 Million | $-38.90 Million | $15.72 Million | ▼ -26.9% |
| 2000 | -1.92x | $-30.47 Million | $-31.11 Million | $15.91 Million | ▲ +43.6% |
| 1999 | -3.40x | $-21.40 Million | $-23.70 Million | $6.30 Million | ▲ +21.0% |
| 1998 | -4.30x | $-8.60 Million | $-9.60 Million | $2.00 Million | — |